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Abstract
Background: Inefficient alternative splicing of the human immunodeficiency virus type 1(HIV-1)
primary RNA transcript results in greater than half of all viral mRNA remaining unspliced.
Regulation of HIV-1 alternative splicing occurs through the presence of suboptimal viral 5' and 3'
splice sites (5' and 3'ss), which are positively regulated by exonic splicing enhancers (ESE) and
negatively regulated by exonic splicing silencers (ESS) and intronic splicing silencers (ISS). We
previously showed that splicing at HIV-1 3'ss A2 is repressed by ESSV and enhanced by the
downstream 5'ss D3 signal. Disruption of ESSV results in increased vpr mRNA accumulation and
exon 3 inclusion, decreased accumulation of unspliced viral mRNA, and decreased virus
production.
Results: Here we show that optimization of the 5'ss D2 signal results in increased splicing at the
upstream 3'ss A1, increased inclusion of exon 2 into viral mRNA, decreased accumulation of
unspliced viral mRNA, and decreased virus production. Virus production from the 5'ss D2 and
ESSV mutants was rescued by transient expression of HIV-1 Gag and Pol. We further show that
the increased inclusion of either exon 2 or 3 does not significantly affect the stability of viral mRNA
but does result in an increase and decrease, respectively, in HIV-1 mRNA levels. The changes in
viral mRNA levels directly correlate with changes in tat mRNA levels observed upon increased
inclusion of exon 2 or 3.
Conclusion: These results demonstrate that splicing at HIV-1 3'ss A1 is regulated by the strength
of the downstream 5'ss signal and that suboptimal splicing at 3'ss A1 is necessary for virus
replication. Furthermore, the replication defective phenotype resulting from increased splicing at
3'ss A1 is similar to the phenotype observed upon increased splicing at 3'ss A2. Further
examination of the role of 5'ss D2 and D3 in the alternative splicing of 3'ss A1 and A2, respectively,
is necessary to delineate a role for non-coding exon inclusion in HIV-1 replication.
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Background
The alternative splicing of retroviral mRNA is unique in
that the inefficient splicing of viral precursor mRNA by the
cellular splicing machinery results in the accumulation of
unspliced mRNA which is necessary for the optimal
expression of structural viral Gag, Gag-Pro, and Gag-Pro-
Pol gene products. Approximately half of all HIV-1 mRNA
remains unspliced; the remainder of the mRNA is either
incompletely spliced, encoding the Env, Vpu, Vif, and Vpr
gene products, or completely spliced, encoding the Tat,
Rev, and Nef gene products.
Greater than 40 unique, alternatively spliced viral mRNAs
are spliced within an HIV-1 infected cell by utilization of
four viral donor splice sites (5'ss) and eight viral acceptor
splice sites (3'ss) [1,2] (Fig. 1A). Regulation of HIV-1 alter-
native splicing occurs primarily because of the presence of
suboptimal 5'ss and 3'ss, which decrease the recognition
by the cellular splicing machinery of the splice signals [3-
5]. Splicing at the viral splice sites is further regulated by
the presence of exonic splicing enhancers (ESE) [6-10]
and exonic/intronic splicing silencers (ESS/ISS) [6,9,11-
14], which bind cellular factors and either promote or
inhibit, respectively, splicing at neighboring splice sites.
Splicing at HIV-1 3'ss A2 results in the accumulation of vpr
mRNA and inclusion of non-coding exon 3 when 3'ss A2
is spliced to the downstream 5'ss D3. We have previously
shown that mutations which either disrupt an ESS within
exon 3 (ESSV) or optimize the 5'ss D3 splicing signal,
result in increased splicing at HIV-1 3'ss A2 [12,15]. Fur-
thermore, increased splicing at HIV-1 3'ss A2 results in
decreased unspliced mRNA accumulation and a reduction
in virus replication, which was restored by second site
reversions that either inactivate 3'ss A2 or 5'ss D3 [15].
In this report we have extended our analysis of HIV-1
alternative splicing by examining the effect on viral repli-
cation of increased splicing at HIV-1 3'ss A1. Increased
splicing at 3'ss A1 results in the accumulation of vif mRNA
and increased inclusion of exon 2 within spliced viral
mRNA species. Our data show that a suboptimal 5'ss sig-
nal downstream of HIV-1 3'ss A1 is necessary for appro-
priate 3'ss utilization, accumulation of unspliced viral
mRNA, Gag protein expression, and efficient virus pro-
duction.
Results
Optimization of HIV-1 5'ss D2 results in increased splicing 
at 3'ss A1 and increased inclusion of exon 2
We have previously shown that disruption of ESSV within
exon 3 results in increased splicing at 3'ss A2 and
decreased unspliced mRNA accumulation. The excessive
splicing phenotype was reversed by disruption of splicing
at 5'ss D3 [15]. Conversely, mutations within 5'ss D3 that
improve the 5'ss signal have been shown to increase splic-
ing at 3'ss A2 [12]. To date, no cis-acting regulatory ele-
ments within exon 2 have been identified. Thus, in an
effort to analyze the effect on HIV-1 replication of
increased splicing at HIV-1 3'ss A1, we generated muta-
tions within the downstream 5'ss D2 (NLD2UP) intended
to increase the sequence homology to the metazoan 5'ss
signal (Fig. 1B).
RT-PCR analysis of NLD2UP-transfected cells revealed
that optimization of the 5'ss D2 signal results in increased
accumulation of spliced viral mRNA that had been spliced
at HIV-1 3'ss A1. Within the 1.8 kb completely spliced
viral mRNA, increased accumulation of nef, rev, and tat
mRNA species containing exon 2 (1.2.5.7, 1.2.3.5.7,
1.2.3.4b/a.7, & 1.2.4.7) was observed in NLD2UP-trans-
fected cells when compared to NL4-3-transfected cells
(Fig. 1C, compare lanes 2 and 4). Similarly, within the 4.0
kb incompletely spliced viral mRNA, increased levels of
env/vpu  mRNA containing exon 2 (1.2.5I, 1.2.3.5I, &
1.2.4I) and vif mRNA (1.2I) were observed in NLD2UP-
transfected cells compared to NL4-3-transfected cells (Fig.
1D, compare lanes 2 and 4). Furthermore, the increased
splicing at HIV-1 3'ss A1 resulting from improvement of
5'ss D2 in NLD2UP-transfected cells was similar to the
increased splicing at HIV-1 3'ss A2 that occurs when ESSV
is disrupted in NEVM-transfected cells (Fig. 1C, lane 3,
and Fig. 1D, lane 3).
Northern blot analysis of viral mRNA from NLD2UP-
transfected cells revealed that the relative accumulation of
unspliced viral mRNA was decreased relative to the total
viral mRNA in cells transfected with either NLD2UP or
NEVM. In contrast, approximately half of viral mRNA
remains unspliced in cells transfected with NL4-3 (Fig.
1F). Furthermore, when the total level of viral mRNA was
taken into account, the increase in the 4.0 kb viral mRNA
species was greater than the increase in 1.8 kb viral mRNA
species in NLD2UP-transfected cells, compared to NEVM-
transfected cells where the 4.0 and 1.8 kb viral mRNA spe-
cies increased to a similar extent (Fig. 1E AND 1F). In
addition there was an approximately two-fold increase in
the level of total viral mRNA in NLD2UP-transfected cells
and an approximately 2-fold decrease in the level of total
viral mRNA in NEVM-transfected cells compared to NL4-
3-transfected cells (Fig. 1F). The decrease in total viral
mRNA in NEVM-transfected is in agreement with our pre-
vious reported results [15].
To quantitatively measure changes in HIV-1 3'ss utiliza-
tion, RNase protection assays were performed using ribo-
probes overlapping the viral splicing signals (Fig. 1A). The
overall level of splicing, as determined by utilization of
HIV-1 5'ss D1, increased by approximately seven-fold in
NLD2UP-transfected cells and three-fold in NEVM-trans-Retrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
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Inefficient inclusion of HIV-1 exon 2 is dependent upon a suboptimal signal at 5'ss D2 Figure 1
Inefficient inclusion of HIV-1 exon 2 is dependent upon a suboptimal signal at 5'ss D2. (A) Map of HIV-1 genome (NL4-3) show-
ing the locations of 5' and 3' splice sites. The positions of Exon 2, Exon 3, and ESSV are indicated above the viral genome. 
Probes used to analyze HIV-1 splicing are shown above and below the viral genome and splice sites. Oligonucleotide primers 
used for RT-PCR analysis of viral splicing are shown above the viral genome. The BSS/SJ4.7A primer pair were used to detect 
the 1.8 kb, completely spliced viral mRNA species. The BSS/KPNA primer pair were used to detect the 4.0 kb incompletely 
spliced viral mRNA species. The probe complementary to the 3'-end of the viral mRNAs used for Northern analysis is indi-
cated by NB. The probes used for the RNase protection assays (DPHV, A1D2, A2D3, and 601c) are represented by lines and 
are complementary to the splice sites to which they overlap. (B) 5'ss D2 within pNL4-3 was mutagenized as shown resulting in 
a consensus 5'ss signal in the infectious molecular clone NLD2UP. The previously described plasmid NEVM [15] was used as a 
control for increased splicing at 3'ss A2. Total RNA samples from Hela cells 48 hours post transfection with the indicated plas-
mids were analyzed by RT-PCR using primers specific for completely spliced viral mRNA (C) or incompletely spliced viral 
mRNA (D). HIV-1 RNA species are indicated on the right side of the gel by exon content, the mRNA to which they encode, 
and mRNA spliced at 3'ss A1 are indicated by plus signs and 3'ss A2 by asterisks. (E) Total cellular RNA from 293T cells 24 
hours post transfection with the indicated plasmids was subjected to Northern blot analysis with a radiolabeled probe (NB) 
complementary to all HIV-1 mRNAs. (F) Northern blots were quantitated and the values shown were normalized to β-actin 
and β-galactosidase mRNA levels and represent the average of three independent experiments. RNA was also subjected to 
RPA analysis using the following riboprobes: DPHV (G), A1D2 (H), A2D3 (I), and 601c (J). Individual panels are representative 
of a single experiment. (K) Viral splice site utilization is represented relative to NL4-3 for each splice site. The values shown 
represent the average of three independents experiments and were normalized to β-actin and β-galactosidase mRNA levels.Retrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
Page 4 of 10
(page number not for citation purposes)
fected cells compared to the level of splicing observed in
NL4-3-transfected cells (Fig. 1G and 1K). When the
sequence homology of 5'ss D2 was increased relative to
the metazoan consensus 5'ss signal there was a six-fold
increase in the utilization of HIV-1 3'ss A1 (vif mRNA and
exon 2 inclusion) compared to the level of splicing in
NL4-3-transfected cells, whereas there was little change in
splicing at 3'ss A1 in NEVM-transfected cells (Fig. 1H & K).
Disruption of ESSV increased splicing at 3'ss A2 by
approximately ten-fold compared to NL4-3, and cells
transfected with NLD2UP utilized 3'ss A2 approximately
two-fold more efficiently than NL4-3-transfected cells
(Fig. 1I and 1K). Only small differences in splicing at HIV-
1 3'ss A4a, A4b, A5, and env mRNA accumulation were
observed in cells transfected with NLD2UP or NEVM
when compared to NL4-3-transfected cells. (Fig. 1J & K).
Interestingly, cells transfected with NLD2UP utilized HIV-
1 3'ss A3 about two-fold more efficiently and cells trans-
fected with NEVM spliced 3'ss A3 two-fold less efficiently
than NL4-3-transfected cells (Fig. 1J and 1K). Alterations
observed in splicing at 3'ss A3 by RNase protection assay
within NLD2UP and NEVM-transfected cells were consist-
ent with the increased and decreased accumulation of tat
mRNA containing exon 2 (1.2.4.7) or exon 3 (1.3.4.7),
respectively, as measured by RT-PCR (Fig. 1C compare
lanes 3 and 4). These results indicate that in addition to
increased splicing at HIV-1 3'ss A1 upon improvement of
5'ss D2 and at 3'ss A2 upon disruption of ESSV, increased
Efficient HIV-1 replication is dependent upon the presence of a suboptimal signal at 5'ss D2 Figure 2
Efficient HIV-1 replication is dependent upon the presence of a suboptimal signal at 5'ss D2. (A) Reverse transcriptase activity 
of cell-free supernatants from 293T cells transfected with either NLD2UP or NEVM mutants. Asterisks indicate a significant 
difference when compared to mock transfected cells from three independent experiments (p < 0.01 by Student's t-test). (B) 
HIV-1 p24 Gag production from transfected 293T cells was measured by subjecting ten-fold serial dilutions of cell-free super-
natants to Western blot analysis using serum from an HIV-1 infected patient. (C and D) Protein from transfected 293T cells 
was subjected to Western blot analysis using serum from an HIV-1 infected patient or antibodies to the indicated cellular or 
viral gene product.Retrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
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Restoration of HIV-1 virion production upon transient Gag, Gag-Pro, and Gag-Pro-Pol expression Figure 3
Restoration of HIV-1 virion production upon transient Gag, Gag-Pro, and Gag-Pro-Pol expression. (A) Open reading frames 
and signals contained within HPdBs. A representation of the HPdBs mRNA (grey box) is shown with the respective viral splice 
sites and splicing signals indicated. (B) Reverse transcriptase activity of cell-free supernatants from 293T cells transfected with 
the indicated plasmids, with or without the co-expression of the vector HPdBs. Black bars indicate the reverse transcriptase 
activity measured upon transient transfection of either HPNd, HPBs, or the indicated pNL4-3 derivative alone. Grey bars indi-
cate the reverse transcriptase activity measured upon transient transfection of the indicated NL4-3 derivative along with HPBs. 
Reverse transcriptase activity represents the average of three independent experiments, normalized to the reverse tran-
scriptase activity of supernatants from pNL4-3 transfected cells. Single asterisk indicates there is no significant difference when 
compared to NL4-3 transfected cells (p > 0.02 by Student's t-test) and double asterisk indicates there is no significant differ-
ence when compared to mock transfected cells (p > 0.2), from three independent experiments. (C) Protein from transfected 
293T cells was subjected to Western blot analysis using serum from an HIV-1 infected patient. The HIV-1 Gag precursor (p55 
Gag) and Gag proteolytic products (CA and MA) are indicated on the right.Retrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
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splicing at 3'ss A1 and A2 also led to either increased or
reduced levels of tat mRNA containing exon 2 or exon 3,
respectively.
Increased splicing at 3'ss A1 disrupts virus production
Analysis of reverse transcriptase activity in cell-free super-
natants from 293T cells that had been transiently trans-
fected with NLD2UP resulted in an approximately ten-
fold decrease in virus production when compared to
pNL4-3-transfected cells (Fig. 2A). Furthermore, the
greater than 90% reduction of virus production observed
by mutagenesis of HIV-1 5'ss D2 was similar to the
decrease observed when ESSV is mutated (Fig. 2A,
NEVM). The ten-fold decrease in viral reverse transcriptase
activity within the supernatants of NLD2UP-transfected
cells correlated with an approximately ten-fold decrease in
p24 Gag accumulation in cell-free supernatants as meas-
ured by Western blot analysis of serial dilutions of viral
supernatants (Fig. 2B). As observed previously with the
NEVM mutant, Gag accumulation was also decreased
within 293T cells transiently transfected with NLD2UP as
measured by Western blot analysis of cellular lysates (Fig.
2C).
To further characterize the defect in HIV-1 production
upon mutagenesis of HIV-1 5'ss D2, HIV-1 structural, reg-
ulatory, and accessory protein expression was measured
by Western blot analysis. Consistent with the mRNA anal-
yses in Fig. 1G, 293T cells transiently transfected with
NLD2UP expressed increased levels of HIV-1 Vif and cells
transiently transfected with NEVM accumulated decreased
levels of Vif when compared to wild-type NL4-3 (Fig. 2D).
Also consistent with the mRNA analyses in Fig. 1H, West-
ern blot analysis of HIV-1 Vpr expression in NEVM-trans-
fected cells indicated increased levels of Vpr whereas cells
transfected with NLD2UP expressed wild-type levels of
Vpr. HIV-1 Rev, Nef, and Env expression within either
NLD2UP or NEVM-transfected cells were at levels compa-
rable to or somewhat greater than wild-type when nor-
malized to levels of co-transfected β-galactosidase. Efforts
to reproducibly detect Tat protein by Western blot were
unsuccessful, and co-transfection of pCMV-Tat along with
NEVM did not rescue the ability to produce wild-type lev-
els of reverse transcriptase activity (data not shown).
Based on the above data we concluded that optimization
of 5'ss signal decreased the levels of cell-associated Gag
and capacity to produce progeny virions to a similar
extent as disruption of ESSV.
Overexpression of an HIV-1 Gag-Pro-Pol plasmid rescues 
production of the 3'ss A1 and A2 oversplicing mutants
The defect in HIV-1 virion production observed upon
increased usage of either 3'ss A1 or A2 correlates with
decreased expression of Gag. In order to confirm that
decreased expression of HIV-1 Gag is responsible for the
disruption of progeny virion production, an expression
vector was generated that expressed HIV-1 Gag-Pro-Pol.
The previously characterized retroviral packaging vector
HPNd contains a nearly intact viral genome, with notable
exceptions including the absence of the ψ RNA packaging
signal and a deletion preventing Env expression [16].
HPNd is transcribed from the CMV promoter but because
of the presence of the HIV-1 TAR and RRE, transcription
of HPNd is still responsive to Tat expression and viral
mRNA accumulation is still dependent upon Rev expres-
sion. HPNd was modified to minimize the potential of
recombination with the 3'ss A1 and A2 oversplicing
mutants, resulting in the vector HPBs (Fig. 3A). HPBs con-
tains a deletion from just downstream of 5'ss D2, main-
taining the entire Gag-Pro-Pol open reading frame, to just
upstream of the RRE.
As expected because HPBs lacks the regulatory genes Tat
and Rev, transient expression of HPNd but not HPBs in
293T cells resulted in near wild-type levels of reverse tran-
scriptase activity in cell free supernatants (Fig. 3B). Fur-
thermore, co-expression of HPBs with NLD2UP or NEVM
restored reverse transcriptase activity to levels obtained
when HPBs was coexpressed with NL4-3. Consistent with
the restoration of reverse transcriptase activity upon co-
expression of HPBs, the intracellular accumulation of p55
Gag and the p24 Capsid and p17 Matrix cleavage products
were restored to wild-type levels in NLD2UP and NEVM-
transfected cells by co-expression of HPBs, whereas cells
transfected with HPBs alone did not express detectable
levels of HIV-1 Gag (Fig. 3C). Rescued virion production
after exogenous expression of Gag-Pro-Pol demonstrates
that the primary defect in virus production in 3'ss A1 and
A2 oversplicing mutants is the inability to accumulate suf-
ficient quantities of unspliced viral mRNA and therefore
express appropriate levels of Gag and Gag-Pro-Pol. Fur-
thermore, since the transient Gag-Pro-Pol expression is
Rev-dependent, it can be inferred from the complementa-
tion observed upon transient expression of Gag-Pro-Pol
that sufficient quantities of Rev are expressed in 3'ss A1
and A2 oversplicing mutants. However, transient Gag-
Pro-Pol expression, although responsive to Tat, is not
dependent on Tat expression [17], therefore inferences
about Tat expression from the 3'ss A1 and A2 oversplicing
mutants cannot be made from these assays.
Viral mRNA stability is not affected by non-coding exon 
inclusion
HIV-1 exon 2 and 3 have been suggested to play a role in
viral mRNA stability, an observation that could possibly
explain the disparity between the overall mRNA accumu-
lation observed within NLD2UP and NEVM-transfected
cells (Fig. 1E & F) [18]. In order to test whether or not
non-coding exon inclusion influences spliced viral mRNA
stability, we transfected 3'ss A1 and A2 oversplicingRetrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
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mutants NLD2UP or VMD3UP and analyzed spliced viral
mRNA by RNase protection assays after treatment with
Actinomycin D. In order to achieve maximal exon 3 inclu-
sion, the vector VMD3UP was generated, which contains
both the NEVM mutation and a previously described
mutation within HIV-1 5'ss D3 that increases the affinity
of 5'ss D3 with the metazoan 5'ss signal [12]. The double
mutation further increases the inclusion of non-coding
exon 3 when compared to either mutation alone. Inclu-
sion of non-coding exons 2 or 3, respectively, in cells
transfected with NLD2UP or VMD3UP was nearly com-
plete within the spliced viral mRNA (Fig. 1C and 1D, and
data not shown).
The level of spliced viral mRNA remaining after 6 hours of
treatment with actinomycin D did not differ whether
inclusion of non-coding exon 2 (D2UP) was increased, or
whether inclusion of non-coding exon 3 was increased
(VMD3UP) (Fig. 4A and 4B). Further analysis of the
spliced mRNA species by RNase protection assays revealed
that there was no difference in the individual stabilities of
the env, tat, rev, and nef spliced viral mRNA species upon
inclusion of non-coding exon 2 and 3 (data not shown).
Furthermore, the relative level of spliced viral mRNA
remained stable throughout the experiment, when com-
pared to the stability of the co-transfected β-galactosidase
mRNA.
Discussion
In this study we have extended our previous findings that
HIV-1 virion production is disrupted upon increased
splicing at HIV-1 3'ss A2 to show that increased splicing at
HIV-1 3'ss A1 also disrupts virus production. Increased
splicing at either 3'ss A1 or A2 results in a substantial
decline in the relative level of unspliced viral mRNA
resulting in decreased Gag protein expression. Two lines
of evidence suggest that decreased Gag expression is the
primary defect in virion production in the 3'ss A1 and A2
splicing mutants. First, expression of a Gag-Pro-Pol
expression plasmid increased virus production in cells
transfected with either the HIV-1 3'ss A1 or A2 oversplic-
ing mutants to near wild type levels. These experiments
strongly suggest that expression of Gag-Pro-Pol proteins is
sufficient to rescue virus production, although from these
experiments we cannot rule out the possibility that other
RNA-mediated activities of the Gag-Pro-Pol expression
plasmid may contribute to the rescue of virus production
from the NLD2UP or NEVM mutants. Second, despite the
greater than 90% decrease in particle production, p24 Gag
accumulation was detected both intracellularly and extra-
cellularly. This demonstrates that the inability to produce
sufficient quantities of unspliced gag mRNA and not a
defect in a downstream step in the virus life cycle is
responsible for the replication defect in the 3'ss A1 or A2
oversplicing mutants.
Increasing the homology of the HIV-1 5'ss D2 to the meta-
zoan consensus 5'ss signal dramatically increased the effi-
ciency by which 3'ss A1 was spliced. Mutations that
increase the homology of the 5'ss D3 also decreased
unspliced viral mRNA accumulation and virion produc-
tion but not as effectively as disrupting ESSV or increasing
the sequence homology of 5'ss D2 (Madsen and Stoltzfus,
preliminary data). The differences observed in the effect of
Effects of non-coding exon inclusion on viral mRNA stability Figure 4
Effects of non-coding exon inclusion on viral mRNA stability. 
(A) RNase-protection mapping of HIV-1 spliced mRNAs 
using the DPHV riboprobe after transient transfection of the 
indicated plasmids and treatment with actinomycin D for the 
indicated times. Quantitation of the changes in accumulation 
of the spliced (B) viral mRNA species after the addition of 
actinomycin D (normalized to cellular β-actin) is shown rela-
tive to the onset of the experiment. The co-transfected 
pCMVβgal110 control was used to measure LacZ turnover, 
and the data shown represents LacZ mRNA levels within 
NL4-3 co-transfected cells. The data shown represent the 
average of three independent experiments.Retrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
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increasing sequence homology of 5'ss D2 and D3 on
unspliced viral mRNA accumulation and virion produc-
tion suggests that HIV-1 exon 2 either contains no nega-
tive regulatory elements or a very weak ESS. We are
currently testing for the presence of positive and negative
splicing regulatory elements within HIV-1 exon 2.
The overall levels of viral mRNA were observed to increase
or decrease in response to increased splicing at HIV-1 3'ss
A1 and A2, respectively. Our studies indicated that the
inclusion of either non-coding exon 2 or 3 has little or no
effect on viral mRNA stability. The presence of non-cod-
ing exon 2 and 3 in viral mRNAs has been implicated in
either the nuclear stabilization or degradation of the viral
mRNAs in which they are present [18]. These previous
studies analyzed the effect of non-coding exon inclusion
on the stability of poly A+ RNA expressed from subge-
nomic viral constructs. In contrast, in our experiments the
stability of total viral RNA that was expressed from intact
viral genomes was analyzed.
Although the alterations in viral mRNA levels observed in
response to increased splicing at HIV-1 3'ss A1 or A2 were
not consistent with the previously described role of non-
coding exon inclusion on viral mRNA stability, changes in
tat mRNA levels correlated with the changes in the overall
viral mRNA levels. Increased tat  mRNA levels were
observed when there was increased splicing at 3'ss A1
whereas decreased tat mRNA levels were observed when
there was increased splicing at 3'ss A2. Differential tat
mRNA accumulation would be expected to correlate with
the respective change in viral transcription due to the abil-
ity of Tat to transactivate transcription from the viral LTR.
Furthermore, it has previously been shown that HIV-1
non-coding exon 2 is included more frequently within tat
mRNA species than non-coding exon 3. The difference in
exon inclusion within the tat mRNA species is in contrast
to the rev and nef mRNA species where exon 3 is preferen-
tially included [2]. Taken together, these observations sug-
gest that the difference in tat mRNA accumulation and the
overall accumulation of viral mRNA in the HIV-1 3'ss A1
and A2 oversplicing mutants may be a consequence of
more efficient splicing of 5'ss D2 to 3'ss A3 than 5'ss D3
to 3'ss A3.
Although not addressed in our studies, the increased splic-
ing of viral mRNA in the HIV-1 3'ss A1 and A2 oversplic-
ing mutants could result in the increased biogenesis of
viral encoded miRNAs derived from spliced viral intron
sequences. Recently, a viral encoded siRNA has been iden-
tified, corresponding to NL4-3 nt 7770–7788, located
between HIV-1 5'ss D4 and 3'ss A7 [19]. The replication
defects shown here did result in decreased unspliced viral
mRNA accumulation relative to the total mRNA level
which would be expected upon increased miRNA biogen-
esis. The viral encoded siRNA would be directed towards
the incompletely spliced viral mRNA as well, which
would also be expected to decrease. However, this was not
the case, as shown in Fig. 1F. Furthermore, we showed
that the stability of spliced viral mRNA species, which
included incompletely spliced viral mRNA, did not
decrease in response to increased viral splicing. These
studies do not conclusively demonstrate whether or not
increased viral miRNA biogenesis occurs upon increased
viral splicing, since it has been shown that Tat abrogates
the effect of miRNA expression [19].
If inclusion of non-coding exons 2 and 3 do not play a
direct role in viral gene expression then why are these
exons present in the viral genome? One possibility is that
that the extent of inclusion or exclusion of exons 2 and 3
may be important in the maintenance of optimal levels of
vif  and  vpr  mRNAs under conditions during infection
where the levels of cellular splicing factors are changing.
An increase in negative factors binding to possible weak
ESS elements within exon 2 and ESSV within exon 3,
would decrease inclusion of these exons and thus, act to
maintain the levels of the incompletely spliced vif and vpr
mRNA. Conversely, an increase in positive factors binding
to possible ESE elements within exons 2 and 3 would
increase inclusion of these exons and act to prevent accu-
mulation of excessive levels of vif and vpr mRNAs. A sec-
ond possibility to explain the presence of exons 2 and 3 is
that 5'ss D2 and D3 may be present to stabilize the incom-
pletely spliced vif and vpr mRNAs by recruitment of U1
snRNP. A similar mechanism has been proposed for 5'ss
D4, which has been shown to be necessary to stabilize
HIV-1 env mRNA [8]. A third possibility is that 5'ss signals
D2 and D3 may be necessary downstream of 3'ss A2 and
A3, respectively, to optimize splicing efficiencies at these
3'ss and to attenuate the negative effects of ESS elements.
In addition to playing a role in the recruitment of splicing
machinery, 5'ss signals can recruit U1 snRNP in the
absence of splicing at the 5'ss, thus activating splicing at
the upstream 3'ss [20]. Further experiments to test the
binding of U1 snRNP to 5'ss D2 and D3 in the presence
and absence of splicing are required to test the role of 5'ss
D2 and D3 in HIV-1 alternative splicing.
Methods
Plasmids
The infectious molecular clone pNL4-3 was obtained
from the NIH AIDS Research and Reference Reagent Pro-
gram [21]. pNLD2UP was derived by site-directed muta-
genesis of pCMV5RIAG, which was generated by ligating
the 2258 nt EcoRI-AgeI fragment of pNL4-3 into pCMV5
[15]. The resulting mutants were then digested with EcoRI
and AgeI and ligated into pNL4-3. The following sense oli-
gonucleotide was used to direct mutagenesis 5'ss D2,
along with the complementary antisense oligonucleotide:Retrovirology 2006, 3:10 http://www.retrovirology.com/content/3/1/10
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5'GGA CCA GCA AAG CTC CTC TGG AAA GGT GAG TGG
GCA GTA GTA ATA CAA G3'. VMD3UP was generated by
site-directed mutagenesis of pNEVM [15] with the previ-
ously described D3ATF primers [12]. The plasmid HPBs
was derived from the vector pHP-dl. Nde/Ase or HPNd
[16], by Klenow treatment followed by blunt-end ligation,
after removal of the HIV-1 sequences corresponding to the
1746 nt BsaBI/NdeI fragment.
Riboprobe template constructs DPHV and 601c were gen-
erated by ligating the 884 nt HindIII/PstI  and 601 nt
EcoRI/KpnI fragments, respectively, of pNL4-3 into pBlue-
script SK+. The A1D2 and A2D3 riboprobe template con-
structs were generated by PCR amplification of pNL4-3
using the following oligonucleotide primers: A1D2 sense,
5'ATC GAA TTC AAA ATT TTC GGG TTT ATT ACA GGG3',
A1D2 antisense, 5'TGA AAG CTT TTC TTC TTG GCA CTA
CTT TTA TGT CAC3', A2D3 sense, 5'GTC GAA TTC AGT
AGA CCC TGA CCT AGC3', A2D3 antisense, 5'TCA AAG
CTT AAC ACT AGG CAA AGG TGG3'. Amplification of
viral DNA containing exon 2 or 3 was performed in 1 ×
AmpliTaq Gold, 0.5 µM each oligonucleotide primer,
0.05 ng Template DNA, 0.2 mM dNTP, 4.5 mM MgCl2,
and 2.5 U AmpliTaq Gold Polymerase for 25 cycles of 30
sec at 95°C, 30 sec at 55°C, and 1 min at 72°C. Viral PCR
products were digested with EcoRI/HindIII  and ligated
into Bluescript SK+. The pMapLacZ riboprobe template
construct was used to analyze LacZ mRNA levels. The β-
actin riboprobe template construct was generated by ligat-
ing the previously described β-actin PCR product [15] into
pGEMT, using the pGEM?T Vector System II (Promega),
according to the manufacturer's recommendations.
Cells
293T and Hela cells were obtained from American Type
Culture Collection, and were cultured as previously
described [12]. For Gag overexpression experiments, 6 µg
of HIV-1 plasmid was calcium phosphate precipitated
with 6 µg of HP plasmid and 1 µg of pCMVβgal110 as pre-
viously described [12,15]. To measure viral mRNA turno-
ver, 293T cells were plated at a density of 6 × 106 cells per
25 mL in a 15 cm dish 48 hours prior to transfection. Cul-
tures were transfected with 75 µg DNA by calcium phos-
phate precipitation as described previously [12,15]. At 24
hours post transfection the cells were equally divided into
five 60 mm dishes. Two hours after re-seeding, fresh
media was added containing 10 µg/mL actinomycin D,
and total RNA and protein was extracted at various times
from 1 to 6 hr as previously described [22].
Analysis of viral replication
In all experiments, 293T and Hela cells were transiently
transfected with viral vectors as described previously
[12,15], and viral replication was analyzed 24 hours post-
transfection. Analysis of reverse-transcriptase activity,
intra-cellular Gag expression, and viral accessory and reg-
ulatory protein expression has been described previously
[15,23]. Western blot analysis was performed by using
polyclonal antibody 2–37 directed against Rev [24] was
used in immunoblotting at a dilution of 1:2000, polyclo-
nal antibody 1–46 directed against Vpr (NIH AIDS
Research and Reference Reagent Program) at a dilution of
1:500, and monoclonal antibody #319, directed against
Vif (NIH AIDS Research and Reference Reagent Program)
was used at a dilution of 1:50. Extracellular Gag was
detected by performing ten-fold serial dilutions of cell-
free supernatants in 0.04 M Tris, pH 6.8, 1% SDS, 10%
glycerol, and 10% β-mercaptoethanol from transfected
293T cells, fractionating the diluted supernatants by SDS-
PAGE, and performing immunoblotting as described pre-
viously for intracellular Gag [25].
Analysis of HIV-1 splicing
Northern blot analysis of HIV-1 mRNA accumulation was
performed as described previously [15]. The LacZ probe
was generated by random-primed labeling of the 1443 nt
AvaI fragment, digested from pCMV-110 β-galactosidase
(β-gal) [26].
RNase protection assays were performed by incubating
1.6 × 106 cpm (HIV-1 probes) and 1.0 × 106 cpm (actin
and lacZ probes), of in vitro transcribed, [α32P] UTP
(Amersham) labeled RNA with 5 µg total cellular RNA.
Radiolabeled probes were in vitro transcribed from linear-
ized DNA templates as previously described [11], exclud-
ing the addition of a cap analog in the transcription
reactions, with T3 RNA polymerase (DPHV and 601C
probes) and T7 RNA polymerase (A1D2, A2D3, actin, and
lacZ probes) (Stratagene). The samples were hybridized
overnight at 57°C (A2D3 probe at 45°C) in a 35 µL reac-
tion containing 40 mM 1 M PIPES pH 6.5, 400 mM NaCl,
and 1 mM EDTA pH 8.0 in deionized formamide. RNase
T1 (100 U) was added in 10 mM Tris pH 7.5, 5 mM EDTA
pH 8.0, and 300 mM NaCl, and the samples were incu-
bated for 30 minutes at 37°C. Fifty micrograms of Protei-
nase K was then added, SDS was added to a final
concentration of 1.5% and the samples were incubated
for 15 minutes at 37°C. The reaction  was extracted with
phenol-chloroform, the RNA in the aqueous phase was
precipitated with ethanol, and the RNA was fractionated
on a 5%  polyacrylamide gel containing 7M urea and 1/2X
TBE at 500 V for 4 hours. The gels were analyzed by auto-
radiography, and the radiolabeled bands were quantitated
using an Instant Imager (Packard).
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